Avantor Inc (NYSE:AVTRpA.PFD)
$ 90.81 0 (0%) Market Cap: - Enterprise Value: - PE Ratio: 66.34 PB Ratio: 3.21 GF Score: 77/100

Avantor Inc at Goldman Sachs Global Healthcare Conference Transcript

Jun 14, 2022 / 03:00PM GMT
Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst

All right. I think we're ready to go. Welcome, everyone. I'm Matt Sykes, the life sciences tools and diagnostics analyst at Goldman Sachs. I have the pleasure of welcoming Avantor here today. We have Michael Stubblefield, the Chief Executive Officer. Move on toward Michael, thank you very much for joining us today.

Michael Stubblefield
Avantor, Inc. - President, CEO & Director

Yes. Thanks, Matt. It's great to be here in person.

Questions & Answers

Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst

Maybe if you could help us set the stage initially and spend a few minutes Avantor, and including a brief review in the most recent quarter.

Michael Stubblefield
Avantor, Inc. - President, CEO & Director

Yes, that's a great place to start and certainly appreciate the opportunity to talk about our business. Avantor is a really unique

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot